Methylprednisolone therapy in multiple sclerosis: a profile of adverse effects.
Open Access
- 1 February 1988
- journal article
- research article
- Published by BMJ in Journal of Neurology, Neurosurgery & Psychiatry
- Vol. 51 (2), 285-287
- https://doi.org/10.1136/jnnp.51.2.285
Abstract
A retrospective analysis of 350 treatment courses using high dose pulsed intravenous methylprednisolone for relapses of multiple sclerosis revealed a low number of adverse effects. This study confirms that high dose methylprednisolone is a safe therapeutic option in multiple sclerosis.This publication has 16 references indexed in Scilit:
- A double-blind controlled trial of high dose methylprednisolone in patients with multiple sclerosis: 1. Clinical effects.Journal of Neurology, Neurosurgery & Psychiatry, 1987
- Intravenous methylprednisolone for multiple sclerosis in relapse.Journal of Neurology, Neurosurgery & Psychiatry, 1985
- CYCLOSPORIN A, METHYLPREDNISOLONE, AND CONVULSIONSThe Lancet, 1982
- Methylprednisolone therapy in multiple sclerosis.Journal of Neurology, Neurosurgery & Psychiatry, 1982
- A DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL OF METHYLPREDNISOLONE PULSE THERAPY IN ACTIVE RHEUMATOID DISEASEThe Lancet, 1982
- Treatment of acute exacerbations of multiple sclerosis with intravenous methyl-prednisolone.Journal of Neurology, Neurosurgery & Psychiatry, 1982
- Possible beneficial effect of high‐dose intravenous steroid therapy in acute demyelinating disease and transverse myelitisNeurology, 1980
- Methylprednisolone pulse therapy in the treatment of polyarteritis nodosaPublished by Oxford University Press (OUP) ,1977
- BENEFICIAL EFFECTS OF METHYLPREDNISOLONE "PULSE" THERAPY IN DIFFUSE PROLIFERATIVE LUPUS NEPHRITISThe Lancet, 1976
- THE EFFECT OF MASSIVE PULSE STEROID THERAPY ON THE WATER CONTENT OF THE RAT BRAINTransplantation, 1972